|English to Chinese: Stroke|
|Source text - English|
Stroke is the second leading cause of death in the Western World and approximately 10 percent of strokes are hemorrhagic in nature. Nearly half of all patients with an intracerebral hemorrhage (ICH) will die within 30 days. Currently, no effective treatment exists for this devastating condition. SPOTLIGHT is a multi-centre study testing the ability of a protein called “recombinant activated factor VII (rFVIIa)” to reduce ICH in patients with a “spot sign” radiographic sign on CT angiography. This research will advance knowledge about ICH and is an essential step toward developing an efficacious emergency treatment protocol for this life-threatening condition.
|Translation - Chinese|
中風在西方國家是第二大死亡原因，且大約 10% 中風的性質是屬於出血性。 幾乎半數發生顱內出血（ICH）的病人會在 30 天內死亡。在目前對這種不幸的狀況並沒有有效的治療方法。SPOTLIGHT 是一項多中心的研究，測試一種稱為「合成活化第七因子」（rFVIIa）這種蛋白質降低病人發生ICH的能力，這些病人在 CT 血管造影時在放射線影像上會出現「點狀徵兆」。這項研究將推進對ICH的了解並且對於發展一種有效的急救處置原則以應付這種有生命危險的狀況而言，此研究是絕對必要的一步。
|Chinese to English: Contract|
|Source text - Chinese|
|Translation - English|
6. Payment guarantee:
Since Party A will invest at a later time than Party B, Party A will provide its share as guarantee and will prepare a Letter of Guarantee to Party B as an integral part of this contract. In the event that Party A is unable to invest according to the plan and after Party B has notified Party A in writing, Party A’s portion of shares will be used to offset the shortage in investment amount. The offset value of shares shall be agreed upon by both parties through discussion. If they fail to reach an agreement, an evaluator accepted by both parties shall conduct the evaluation.
7. Contract effectiveness:
This contract shall take effect once both parties have signed it and affixed their seals. This contract is issued in quadruplicate with two copies given to each party. Provided there are any matters not covered in the contract, both parties shall negotiate further to establish supplementary terms.